Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 mg - 200 mg - 245 mg (efavirenz 600 mg + emtricitabine 200 mg + tenofovir disoproxil 245 mg tablet (or.)) · CNK 4204434

Product information

Product name
Efavirenz/Emtricitabine/Tenofovir Disoproxil Mylan 600 mg - 200 mg - 245 mg
Pack
90 (3 x 30)
Active ingredient
efavirenz 600 mg + emtricitabine 200 mg + tenofovir disoproxil 245 mg tablet (or.)
CNK Code
4204434
Availability score
0 / 10
Historic availability score
Locked

Product properties

CAS code
154598-52-4
ATC code
J05AR06
Company
Mylan Pharmaceuticals
Pharmaceutical form
Film-coated tablet
Ex-factory price
€490.95
Authorisation number
EU/1/17/1222/002
GTIN
05712440013094
Delivery mode
M42
Delivery environment
Public
CTI Extended
519964-02

Pharmacist Assessment

Assessment title
Not available
Assessment description

This product is officially temporarily unavailable (reason: Other reason) and is no longer being supplied in practice (score 0/10). Switch to an alternative.

Equivalent products

Tier A: Direct equivalents

…

Tier B: Galenic alternatives

…

Tier C: Strength alternatives

…

Tier D: ATC equivalents (parallel import)

…

Tier E: Active substances (magistral)

…

Stock overview

Availability in Freemium
  • 0 of 18 warehouse locations have stock
  • 0 of the 3 wholesalers have stock

Detailed stock insights are available for registered users

Create a free Curadar Freemium account to view detailed stock data from Febelco, Phoenix and CERP.

Status history (PharmaStatus)

Temporarily unavailable Active
-

Other reason

One or two alternative packsizes available

Composition

5 ingredients

Ingredients
Substance Type Strength CAS
Substance
Efavirenz
Type
Active ingredient
Strength
600 mg
CAS
154598-52-4
Substance
Tenofovirdisoproxilmaleaat
Type
Active ingredient
Strength
CAS
Substance
Emtricitabine
Type
Active ingredient
Strength
200 mg
CAS
143491-57-0
Substance
Lactosemonohydraat
Type
Excipient
Strength
105.5 mg
CAS
Substance
Natriummetabisulfiet
Type
Excipient
Strength
7.5 mg
CAS

Additional information

Leaflet
Download leaflet
SPC
Download SPC
BCPI
View on BCPI
PharmaStatus
View on PharmaStatus

Availability statistics

Current status
Temporarily unavailable
Days unavailable (last year)
560 days
Number of status changes
2
Active supply problems
1
Last change
10/10/2025